• TickerOBSV
  • ISINCH0346177709
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountrySwitzerland

Analysts

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Linzagolix/Fibroid: PRIMROSE-1 Enrollment Complete; Ph3 Results in Q4:19-Q1:20

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Linzagolix/Fibroid: PRIMROSE-1 Enrollment Complete; Ph3 Results in Q4:19-Q1:20

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Ashiq Mubarack ...
  • David Nierengarten
  • Jeffrey La Rosa
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
  • Shveta Dighe

The Week Ahead in Life Sciences

Liana Moussatos ...
  • Shveta Dighe

Nolasiban and Linzagolix Clinical Data Presentations at ESHRE

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ValuEngine Rating and Forecast Report for OBSV

ResearchPool Subscriptions

Get the most out of your insights

Get in touch